Skip to main content

Advertisement

SpringerLink
Log in

Topical antibacterials are the mainstay of therapy for bacterial keratitis

  • New Drugs and Therapeutics
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Callegan MC, O’Callaghan RJ, Hill JM. Pharmacokinetic considerations in the treatment of bacterial keratitis. Clin Pharmacokinet 1994; 27: 129–49

    Article  PubMed  CAS  Google Scholar 

  2. Parks DJ, Abrams DA, Sarfarazi FA, et al. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of ulcerative keratitis. Am J Ophthalmol 1993; 115: 471–7

    PubMed  CAS  Google Scholar 

  3. British National Formulary No. 27. London: The Pharmaceutical Press, 1994; 385–6

  4. Physicians GenRx. New York: Data Pharmaceutica Inc., 1994

  5. Barza M. Anatomical barriers for antimicrobial agents. Eur J Clin Microbiol Infect Dis 1993; 12 Suppl. 1; 31–5

    Article  Google Scholar 

  6. Barza M. Antibacterial agents in the treatment of ocular infections. Infect Dis Clin North Am 1989; 3: 533–51

    PubMed  CAS  Google Scholar 

  7. Baum J. Therapy for ocular bacterial infection. Trans Ophthalmol Soc UK 1986; 105: 69–77

    PubMed  Google Scholar 

  8. Baum J, Barza M. Topical vs subconjunctival treatment of bacterial corneal ulcers. Ophthalmology 1983; 90: 162–8

    PubMed  CAS  Google Scholar 

  9. Liesegang TJ. Bacterial and fungal keratitis. In: Kaufman HE, et al., editor. The cornea. New York: Churchill Livingstone, 1988: 217–70

    Google Scholar 

  10. Snyder ME, Katz HR. Ciprofloxacin-resistant bacterial keratitis. Am J Ophthalmol 1992; 114; 336

    PubMed  CAS  Google Scholar 

  11. Wilhelmus KR, Hyndiuk RA, Caldwell DR, et al. 0.3% ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis. Arch Ophthalmol 1993; 111: 1210–18

    Article  PubMed  CAS  Google Scholar 

  12. Hobden JA, O’Callaghan RJ, Insler MS, et al. Ciprofloxacin ointment versus ciprofloxacin drops for therapy of experimental Pseudomonas keratitis. Cornea 1993; 12: 138–41

    Article  PubMed  CAS  Google Scholar 

  13. Mondino BJ. Collagen shields. Am J Ophthalmol 1991; 112: 587–90

    PubMed  CAS  Google Scholar 

  14. American Academy of Ophthalmology: Clinical Alert 11/1. Corneal toxicity with antibiotic steroid-soaked collagen shields. Public health committee clinical alert program. San Francisco: American Academy of Ophthalmology, 1990

    Google Scholar 

  15. Grossman RE, Chu DF, Lee DA. Regional ocular gentamicin levels after transcorneal and transscleral iontophoresis. Invest Ophthalmol Vis Sci 1990; 31: 909–16

    PubMed  CAS  Google Scholar 

  16. Carmichael TR, Gelfand Y, Welsh NH. Topical corticosteroids in the treatment of central and paracentral corneal ulcers. Br J Ophthalmol 1990; 74: 528–31

    Article  PubMed  CAS  Google Scholar 

  17. Lee BL, Matoba AY, Osato MS, et al. The solubility of antibiotic and corticosteroid combinations. Am J Ophthalmol 1992; 114: 212–5

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Topical antibacterials are the mainstay of therapy for bacterial keratitis. Drugs Ther. Perspect 5, 12–14 (1995). https://doi.org/10.2165/00042310-199505020-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199505020-00005

Keywords

Search

Navigation